UNDIAGNOSED GLUCOSE-INTOLERANCE IN THE COMMUNITY - THE ISLE-OF-ELY DIABETES PROJECT

被引:148
作者
WILLIAMS, DRR
WAREHAM, NJ
BROWN, DC
BYRNE, CD
CLARK, PMS
COX, BD
COX, LJ
DAY, NE
HALES, CN
PALMER, CR
SHACKLETON, JR
WANG, TWM
机构
[1] Department of Community Medicine, Institute of Public Health, University of Cambridge, Cambridge
[2] Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge
[3] Ely, St Mary's Street Surgery
关键词
GLUCOSE INTOLERANCE; TYPE 2 DIABETES MELLITUS; PREVALENCE; IMPAIRED GLUCOSE TOLERANCE;
D O I
10.1111/j.1464-5491.1995.tb02058.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Isle of fly Diabetes Project is a prospective population-based study of the aetiology and pathogenesis of Type 2 diabetes mellitus. Between 1990 and 1992, 1156 subjects aged between 40 and 65 years underwent a standard 75 g oral glucose tolerance test (OGTT). A total of 1122 individuals who were not known to have diabetes completed the test and were classified according to WHO criteria; 51 subjects (4.5 %) had previously undiagnosed diabetes and 188 (16.7 %) had impaired glucose tolerance. The subjects with newly diagnosed glucose intolerance were significantly older, more obese, and shorter than those with normal glucose tolerance. Blood pressure, cholesterol, triglyceride, and LDL-cholesterol concentrations were elevated and HDL-cholesterol levels were lower among those with abnormal rather than normal glucose tolerance. In multiple regression analyses stratified by gender and including age, body mass index, and the waist-hip ratio as covariates, there were significant differences between those with normal and abnormal glucose intolerance in blood pressure, triglyceride, and HDL-cholesterol, but not total or LDL-cholesterol. In both male and female subjects, height had a significant independent negative association with the plasma glucose at 120 min after administration of oral glucose (standardized beta coefficient = -0.12, p<0.01).
引用
收藏
页码:30 / 35
页数:6
相关论文
共 28 条
  • [1] Nabarro JDN, Diabetes in the United Kingdom: some facts and figures, Diabetic Med, 5, pp. 816-822, (1988)
  • [2] Neil HAW, Gatling W, Mather HM, Thompson AV, Thorogood M, Fowler GH, Et al., The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain, Diabetic Med, 4, pp. 539-543, (1987)
  • [3] Diabetes Mellitus, (1985)
  • [4] Williams DRR, Byrne C, Clark PMS, Cox L, Day NE, Rayman G, Et al., Raised proinsulin concentration as early indicator of β cell dysfunction, Br Med J, 303, pp. 95-96, (1991)
  • [5] Brown DC, Byrne CD, Clark PMS, Cox BD, Day NE, Hales CN, Et al., Height and glucose tolerance in adult subjects, Diabetologia, 34, pp. 531-533, (1991)
  • [6] Anthropometric Standardization Reference Manual, (1988)
  • [7] Friedewald WT, Levy RI, Fredrickson DS, Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, pp. 499-502, (1972)
  • [8] Clayton D, Hills M, Statistical Models in Epidemiology, (1993)
  • [9] Charles MA, Fontbonne A, Thibult N, Warnet J-M, Rosselin GE, Eschwege E, Risk factors for NIDDM in white population. Paris Prospective Study, Diabetes, 40, pp. 796-799, (1991)
  • [10] Skarfors ET, Selinus KI, Lithell HO, Risk factors for developing non‐insulin dependent diabetes: a 10‐year follow up of men in Uppsala, Br Med J, 303, pp. 755-760, (1991)